This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
pms-REPAGLINIDE (2017-04-04)
- Starting date:
- April 4, 2017
- Posting date:
- April 19, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-63042
Affected Products
A. pms-REPAGLINIDE 0.5 mg
B. pms-REPAGLINIDE 1 mg
Reason
Out of specification for degradation product during stability testing in affected lot.
Depth of distribution
Retailers across Canada
Affected products
A. pms-REPAGLINIDE 0.5 mg
DIN, NPN, DIN-HIM
DIN 02354926
Dosage form
Tablet
Strength
0.5 mg
Lot or serial number
- 1504536
- 1600499
Companies
- Recalling Firm
-
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
B. pms-REPAGLINIDE 1 mg
DIN, NPN, DIN-HIM
DIN 02354934
Dosage form
Tablet
Strength
1 mg
Lot or serial number
- 1601071
Companies
- Recalling Firm
-
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA